InspireMD Inc
NASDAQ:NSPR

Watchlist Manager
InspireMD Inc Logo
InspireMD Inc
NASDAQ:NSPR
Watchlist
Price: 2.65 USD 2.71% Market Closed
Market Cap: 68.1m USD
Have any thoughts about
InspireMD Inc?
Write Note

Intrinsic Value

NSPR doesn't have a meaningful market cap.
NSPR's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one NSPR stock under the Base Case scenario is 2.62 USD. Compared to the current market price of 2.65 USD, InspireMD Inc is Overvalued by 1%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

NSPR Intrinsic Value
2.62 USD
Overvaluation 1%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
InspireMD Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for NSPR cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about NSPR?
Bearish
Neutral
Bullish

Fundamental Analysis

Economic Moat
InspireMD Inc

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about InspireMD Inc

Provide an overview of the primary business activities
of InspireMD Inc.

What unique competitive advantages
does InspireMD Inc hold over its rivals?

What risks and challenges
does InspireMD Inc face in the near future?

Has there been any significant insider trading activity
in InspireMD Inc recently?

Summarize the latest earnings call
of InspireMD Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for InspireMD Inc.

Provide P/S
for InspireMD Inc.

Provide P/E
for InspireMD Inc.

Provide P/OCF
for InspireMD Inc.

Provide P/FCFE
for InspireMD Inc.

Provide P/B
for InspireMD Inc.

Provide EV/S
for InspireMD Inc.

Provide EV/GP
for InspireMD Inc.

Provide EV/EBITDA
for InspireMD Inc.

Provide EV/EBIT
for InspireMD Inc.

Provide EV/OCF
for InspireMD Inc.

Provide EV/FCFF
for InspireMD Inc.

Provide EV/IC
for InspireMD Inc.

Show me price targets
for InspireMD Inc made by professional analysts.

What are the Revenue projections
for InspireMD Inc?

How accurate were the past Revenue estimates
for InspireMD Inc?

What are the Net Income projections
for InspireMD Inc?

How accurate were the past Net Income estimates
for InspireMD Inc?

What are the EPS projections
for InspireMD Inc?

How accurate were the past EPS estimates
for InspireMD Inc?

What are the EBIT projections
for InspireMD Inc?

How accurate were the past EBIT estimates
for InspireMD Inc?

Compare the revenue forecasts
for InspireMD Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of InspireMD Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of InspireMD Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of InspireMD Inc compared to its peers.

Compare the P/E ratios
of InspireMD Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing InspireMD Inc with its peers.

Analyze the financial leverage
of InspireMD Inc compared to its main competitors.

Show all profitability ratios
for InspireMD Inc.

Provide ROE
for InspireMD Inc.

Provide ROA
for InspireMD Inc.

Provide ROIC
for InspireMD Inc.

Provide ROCE
for InspireMD Inc.

Provide Gross Margin
for InspireMD Inc.

Provide Operating Margin
for InspireMD Inc.

Provide Net Margin
for InspireMD Inc.

Provide FCF Margin
for InspireMD Inc.

Show all solvency ratios
for InspireMD Inc.

Provide D/E Ratio
for InspireMD Inc.

Provide D/A Ratio
for InspireMD Inc.

Provide Interest Coverage Ratio
for InspireMD Inc.

Provide Altman Z-Score Ratio
for InspireMD Inc.

Provide Quick Ratio
for InspireMD Inc.

Provide Current Ratio
for InspireMD Inc.

Provide Cash Ratio
for InspireMD Inc.

What is the historical Revenue growth
over the last 5 years for InspireMD Inc?

What is the historical Net Income growth
over the last 5 years for InspireMD Inc?

What is the current Free Cash Flow
of InspireMD Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for InspireMD Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
InspireMD Inc

Current Assets 46.4m
Cash & Short-Term Investments 40.4m
Receivables 2.3m
Other Current Assets 3.7m
Non-Current Assets 4.1m
PP&E 3.1m
Other Non-Current Assets 996k
Current Liabilities 7.3m
Accounts Payable 1.3m
Accrued Liabilities 5.8m
Other Current Liabilities 186k
Non-Current Liabilities 1.9m
Other Non-Current Liabilities 1.9m
Efficiency

Earnings Waterfall
InspireMD Inc

Revenue
6.8m USD
Cost of Revenue
-5.3m USD
Gross Profit
1.5m USD
Operating Expenses
-31.5m USD
Operating Income
-29.9m USD
Other Expenses
1.7m USD
Net Income
-28.2m USD

Free Cash Flow Analysis
InspireMD Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

NSPR Profitability Score
Profitability Due Diligence

InspireMD Inc's profitability score is 25/100. The higher the profitability score, the more profitable the company is.

Exceptional Revenue Growth Forecast
Exceptional 3-Years Revenue Growth
Positive Gross Profit
Exceptional 1-Year Revenue Growth
25/100
Profitability
Score

InspireMD Inc's profitability score is 25/100. The higher the profitability score, the more profitable the company is.

NSPR Solvency Score
Solvency Due Diligence

InspireMD Inc's solvency score is 61/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Low D/E
Low Altman Z-Score
61/100
Solvency
Score

InspireMD Inc's solvency score is 61/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

NSPR Price Targets Summary
InspireMD Inc

Wall Street analysts forecast NSPR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NSPR is 4.59 USD with a low forecast of 4.55 USD and a high forecast of 4.73 USD.

Lowest
Price Target
4.55 USD
72% Upside
Average
Price Target
4.59 USD
73% Upside
Highest
Price Target
4.73 USD
78% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for NSPR?

Click here to dive deeper.

Dividends

InspireMD Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for NSPR is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

NSPR Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

InspireMD Inc Logo
InspireMD Inc

Country

Israel

Industry

Health Care

Market Cap

68.2m USD

Dividend Yield

0%

Description

InspireMD, Inc. operates as a medical device company, which engages in the development and commercialization of the stent platform technology for the treatment of complex vascular and coronary disease. The firm is focusing on the development and commercialization of its MicroNet stent platform technology for the treatment of vascular and coronary disease. Its MicroNet, a micron mesh sleeve, is wrapped over a stent to provide embolic protection in stenting procedures. Its CGuard carotid embolic prevention system (CGuard EPS) combines its MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. Its MGuard Prime Embolic Protection System (MGuard Prime EPS) is marketed for use in patients with acute coronary syndromes, notably acute myocardial infarction (heart attack) and saphenous vein graft coronary interventions (bypass surgery). The company markets and sells MGuard Prime EPS, a bare-metal cobalt-chromium based stent, for the treatment of coronary disease in the European Union. The company is also developing a neurovascular flow diverter (NGuard), which is an endovascular device.

Contact

TEL AVIV-YAFO
4 Menorat Hamaor St.

IPO

2013-04-12

Employees

52

Officers

President, CEO & Director
Mr. Marvin L. Slosman
CFO, Chief Administrative Officer, Secretary & Treasurer
Mr. Craig Shore
Chief Commercial Officer
Mr. Shane Thomas Gleason
Chief Operating Officer
Mr. Andrea Tommasoli
Senior Vice President of Finance & HR
Mr. Amir Kohen
Executive Vice President of Clinical & Medical Affairs
Dr. Patrick A. Verta DVM, M.D., MS Stat
Show More
Executive VP & GM of North America
Mr. Pete J. Ligotti
Special Advisor to the Board
Dr. Sol J. Barer Ph.D.
Show Less

See Also

Discover More
What is the Intrinsic Value of one NSPR stock?

The intrinsic value of one NSPR stock under the Base Case scenario is 2.62 USD.

Is NSPR stock undervalued or overvalued?

Compared to the current market price of 2.65 USD, InspireMD Inc is Overvalued by 1%.

Back to Top